Allstate Corporation’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-547	Closed	-$129K	–	753
2021 Q3	$129K	Sell	547 -13	-2%	-$3.07K	0.01%	689
2021 Q2	$190K	Buy	560 +13	+2%	+$4.41K	0.01%	711
2021 Q1	$221K	Buy	547 +62	+13%	+$25K	0.01%	702
2020 Q4	$323K	Buy	+485	New	+$323K	0.01%	600